As Regulatory Focus has extensively reported in the past, FDA has long been interested in making it easier for all drug companies—not just innovative manufacturers—to update the safety labeling on drug products.
If you want to submit SPL and that too in R4 format as an original submission, it is possible.
In SPL, FDA provides terminology list, which has some terms with specific codes.